Halozyme Therapeutics
HALO
#2488
Rank
A$8.92 B
Marketcap
$70.18
Share price
-0.13%
Change (1 day)
18.40%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of September 2024 : A$3.25 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are A$3.25 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$2.54 B-5.99%
2022-12-31A$2.70 B77.64%
2021-12-31A$1.52 B101.99%
2020-12-31A$0.75 B-6.69%
2019-12-31A$0.80 B29.33%
2018-12-31A$0.62 B-6.17%
2017-12-31A$0.66 B83.57%
2016-12-31A$0.36 B45.39%
2015-12-31A$0.24 B23.04%
2014-12-31A$0.20 B77.71%
2013-12-31A$0.11 B-11.98%
2012-12-31A$0.12 B102.15%
2011-12-31A$64.13 M-28.68%
2010-12-31A$89.92 M4.71%
2009-12-31A$85.88 M-20.86%
2008-12-31A$0.10 B-8.3%
2007-12-31A$0.11 B102.39%
2006-12-31A$58.46 M108.59%
2005-12-31A$28.03 M32.24%
2004-12-31A$21.19 M2334.32%
2003-12-31A$0.87 M112.77%
2002-12-31A$0.4 M699.44%
2001-12-31A$0.05 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$0.68 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$116.10 B 3,469.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$40.40 B 1,142.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$337.04 B 10,262.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$213.60 B 6,467.19%๐Ÿ‡ซ๐Ÿ‡ท France
A$273.79 B 8,317.59%๐Ÿ‡บ๐Ÿ‡ธ USA